OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 03, 2020
Risk-based decision-making is impacting all aspects of manufacturing quality from raw material supply to facility inspections.
August 10, 2020
Citing undisclosed allegations against Kodak, the DFC placed a hold on a potential $765 million loan to launch US-based API manufacturing.
November 02, 2019
Several factors must be considered when reformulating APIs for pediatric, geriatric, and other specialty patient populations.
August 02, 2019
The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.
July 02, 2019
Nanotechnology is enabling enhanced bioavailability, improved stability, and targeted delivery of challenging APIs.
June 19, 2019
New CDMO facility supports early-stage API manufacturing and scale up.
February 19, 2019
In a deal worth $530 million, the companies will develop and commercialize an anti-epileptic drug candidate in Europe.
December 02, 2018
Antibody-based drugs offer new mechanisms of action and greater specificity.
November 02, 2018
Demand for highly potent APIs continues to rise.
October 02, 2018
Integration of new modeling and analytical tools with flow chemistry are notable trends.